Demographic, Clinical, Biological, Treatment Characteristics and Cardiovascular Events of Patients With Heart Failure in Vietnam: a Multicenter Prospective Observational Study
Overview
- Phase
- Not Applicable
- Intervention
- Optimal treatment
- Conditions
- Heart Failure
- Sponsor
- University Medical Center Ho Chi Minh City (UMC)
- Enrollment
- 2500
- Locations
- 1
- Primary Endpoint
- Heart failure rehospitalization
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
Describe the clinical characteristics, paraclinical features, and treatment during hospitalization, as well as at 1, 3, and 12 months post-discharge, of heart failure patients at selected cardiovascular centers in Vietnam.
Detailed Description
Study Design: Prospective cohort study Study Subjects: Patients discharged with a diagnosis of heart failure with reduced or mildly reduced ejection fraction. Inclusion Criteria: * Patients aged 18 years and older * Diagnosed with heart failure at the time of discharge * Have an ejection fraction (based on imaging modalities such as echocardiography or cardiac MRI) recorded closest to the time of discharge, showing a left ventricular ejection fraction of less than 50% Exclusion Criteria: * Patients and their relatives do not have means of communication with healthcare staff (phone, computer, messaging, etc.) * Patients do not reside in Vietnam after discharge Data Collection: * All patients meeting the criteria at the time of discharge during the study period will be continuously included. Information regarding demographic data, clinical presentation, biological markers, and in-hospital treatment characteristics will be collected using standardized data definitions from EuroHeart data standards for heart failure. * Periodically after hospital discharge (e.g., 1 month, 3 months, 12 months post-discharge), patients will be contacted by investigators to gather information on their current status, medications, and any cardiovascular events, including rehospitalizations, death, and current medical treatment. * Data entry will be performed using the REDCap project at the University of Medicine and Pharmacy, Ho Chi Minh City (https://redcap.umc.edu.vn/)
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients aged 18 years and older
- •Diagnosed with heart failure at the time of discharge
- •Have an ejection fraction (based on imaging modalities such as echocardiography or cardiac MRI) recorded closest to the time of discharge, showing a left ventricular ejection fraction of less than 50%
Exclusion Criteria
- •Patients and their relatives do not have means of communication with healthcare staff (phone, computer, messaging, etc.)
- •Patients do not reside in Vietnam after discharge
Arms & Interventions
Heart failure with reduced or mildly reduced ejection fraction
Intervention: Optimal treatment
Outcomes
Primary Outcomes
Heart failure rehospitalization
Time Frame: 12 months
Patient rehospitalization due to cardiovascular causes, excluding apparent non-cardiac causes.
All-cause mortality
Time Frame: 12 months
Death from any cause
Secondary Outcomes
- Guideline-directed medical therapy detail(12 months)
- Major adverse cardiovascular events(12 months)